• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

获得性穿通性皮肤病:来自一个中心的95例患者的临床和组织病理学分析。

Acquired Perforating Dermatosis: Clinical and Histopathological Analysis of 95 Patients From One Center.

作者信息

Edek Yusuf Can, Aypek Yağmur, Öğüt Betül, Erdem Özlem, Adışen Esra

机构信息

Department of Dermatology, Gazi University Faculty of Medicine, Ankara, Turkey.

Department of Pathology, Gazi University Faculty of Medicine, Ankara, Turkey.

出版信息

Dermatol Pract Concept. 2024 Apr 1;14(2):e2024100. doi: 10.5826/dpc.1402a100.

DOI:10.5826/dpc.1402a100
PMID:38810077
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11135951/
Abstract

INTRODUCTION

Acquired perforating dermatosis (APD) is a disease group characterized by transepidermal elimination of dermal connective tissue materials such as collagen, elastic fibers, and keratin through the epidermis and observed with pruritic skin lesions.

OBJECTIVES

In this study, we aim to clarify the clinical, histopathological, and dermoscopic characteristics of APD, identify the associated systemic disease, and figure out treatment options.

METHODS

This study was designed as a single-center retrospective, observational, cross-sectional study. We evaluated all accessible APD cases between January 2004 and June 2022 in a tertiary care hospital.

RESULTS

A total of 95 patients with confirmed APD were included in the study. Sixty percent of the patients were women and 40% were men. The median age at diagnosis was 63.1 years (35-85 years). The most common site of lesions was the lower extremities which were detected in 86.31% of the patients. The concomitant systemic disease was identified in 84.21% of the patients. The most common systemic disease was type 2 diabetes mellitus (65.26%). Antihistamines and topical corticosteroids were the most commonly prescribed treatment agents.

CONCLUSIONS

Transepidermal elimination of dermal connective tissue components is a feature of APD and the disease usually presents with pruritic papules and nodules with central keratotic crust or plug. The diagnosis of APD requires a clinical examination and histological investigation. APD is usually accompanied by systemic comorbidities. There are several topical and systemic medications available for APD, however, sometimes the therapy might be challenging.

摘要

引言

获得性穿通性皮肤病(APD)是一组以真皮结缔组织物质(如胶原蛋白、弹性纤维和角蛋白)经表皮排出为特征,并伴有瘙痒性皮肤损害的疾病。

目的

在本研究中,我们旨在阐明APD的临床、组织病理学和皮肤镜特征,确定相关的全身性疾病,并找出治疗方案。

方法

本研究设计为一项单中心回顾性观察性横断面研究。我们评估了2004年1月至2022年6月期间在一家三级护理医院就诊的所有可获取的APD病例。

结果

本研究共纳入95例确诊为APD的患者。其中60%为女性,40%为男性。诊断时的中位年龄为63.1岁(35 - 85岁)。最常见的皮损部位是下肢,86.31%的患者在此部位出现病变。84.21%的患者伴有全身性疾病。最常见的全身性疾病是2型糖尿病(65.26%)。抗组胺药和外用糖皮质激素是最常用的治疗药物。

结论

真皮结缔组织成分经表皮排出是APD的一个特征,该疾病通常表现为伴有中央角化性痂皮或栓子的瘙痒性丘疹和结节。APD的诊断需要临床检查和组织学检查。APD通常伴有全身性合并症。有几种外用和全身性药物可用于治疗APD,然而,有时治疗可能具有挑战性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d2b/11135951/6c92d9276983/dp1402a100g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d2b/11135951/a2150a1ef81f/dp1402a100g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d2b/11135951/268171ec9cbc/dp1402a100g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d2b/11135951/87831ba19590/dp1402a100g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d2b/11135951/6c92d9276983/dp1402a100g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d2b/11135951/a2150a1ef81f/dp1402a100g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d2b/11135951/268171ec9cbc/dp1402a100g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d2b/11135951/87831ba19590/dp1402a100g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d2b/11135951/6c92d9276983/dp1402a100g004.jpg

相似文献

1
Acquired Perforating Dermatosis: Clinical and Histopathological Analysis of 95 Patients From One Center.获得性穿通性皮肤病:来自一个中心的95例患者的临床和组织病理学分析。
Dermatol Pract Concept. 2024 Apr 1;14(2):e2024100. doi: 10.5826/dpc.1402a100.
2
Evaluation of clinicopathological and treatment characteristics of 80 patients with acquired perforating dermatosis.评价 80 例获得性穿孔性皮肤病患者的临床病理及治疗特点。
Dermatol Ther. 2020 Nov;33(6):e14465. doi: 10.1111/dth.14465. Epub 2020 Nov 5.
3
Acquired Perforating Dermatosis获得性穿通性皮肤病
4
Clinical characteristics and prognosis of acquired perforating dermatosis: A case report.获得性穿通性皮肤病的临床特征与预后:一例报告
Exp Ther Med. 2020 Jun;19(6):3634-3640. doi: 10.3892/etm.2020.8651. Epub 2020 Apr 9.
5
A clinicopathologic study of thirty cases of acquired perforating dermatosis in Korea.韩国30例获得性穿通性皮肤病的临床病理研究。
Ann Dermatol. 2014 Apr;26(2):162-71. doi: 10.5021/ad.2014.26.2.162. Epub 2014 Apr 30.
6
Expression of the 67-kDa elastin receptor in perforating skin disorders.67-kDa弹性蛋白受体在穿通性皮肤病中的表达。
Br J Dermatol. 2002 Jan;146(1):74-9. doi: 10.1046/j.1365-2133.2002.04550.x.
7
Acquired perforating dermatosis successfully treated with photodynamic therapy.获得性穿孔性皮肤病经光动力疗法治疗后获得成功。
Photodermatol Photoimmunol Photomed. 2012 Feb;28(1):50-2. doi: 10.1111/j.1600-0781.2011.00634.x.
8
Acquired perforating dermatosis: A clinicopathologic study, and the features of dermoscopy and reflective confocal microscopy of 37 cases.获得性穿孔性皮肤病:37 例的临床病理研究及皮肤镜和反射共聚焦显微镜特征。
Skin Res Technol. 2023 Jul;29(7):e13416. doi: 10.1111/srt.13416.
9
Acquired perforating dermatosis: a report of 8 cases.获得性穿通性皮肤病:8例报告。
Actas Dermosifiliogr. 2014 Jul-Aug;105(6):e39-43. doi: 10.1016/j.ad.2013.09.014. Epub 2014 Jan 17.
10
Acquired perforating dermatosis: clinicopathological features in twenty-two cases.获得性穿通性皮肤病:22例临床病理特征
J Eur Acad Dermatol Venereol. 2006 Jul;20(6):679-88. doi: 10.1111/j.1468-3083.2006.01571.x.

本文引用的文献

1
Lichen planus pigmentosus inversus with nail involvement following COVID-19 vaccination: A case report.新冠疫苗接种后伴指甲受累的反向性色素沉着扁平苔藓:一例报告
Dermatol Ther. 2022 Nov;35(11):e15809. doi: 10.1111/dth.15809. Epub 2022 Sep 20.
2
Can Covid-19 vaccines cause or exacerbate bullous pemphigoid? A report of seven cases from one center.新冠疫苗会引发或加重大疱性类天疱疮吗?来自一个中心的7例报告。
Int J Dermatol. 2022 May;61(5):626-627. doi: 10.1111/ijd.16086. Epub 2022 Jan 26.
3
New-onset leukocytoclastic vasculitis after COVID-19 vaccine.
新冠疫苗接种后新发白细胞破碎性血管炎
Int J Dermatol. 2021 Oct;60(10):1305-1306. doi: 10.1111/ijd.15777. Epub 2021 Jul 9.
4
Psoriasis flare-up associated with second dose of Pfizer-BioNTech BNT16B2b2 COVID-19 mRNA vaccine.与辉瑞-生物科技公司的第二剂BNT16B2b2新冠mRNA疫苗相关的银屑病发作。
J Eur Acad Dermatol Venereol. 2021 Oct;35(10):e632-e634. doi: 10.1111/jdv.17449. Epub 2021 Jun 24.
5
Dermoscopy Features of Acquired Perforating Dermatosis Among 39 Patients.39例获得性穿通性皮肤病的皮肤镜特征
Front Med (Lausanne). 2021 Apr 8;8:631642. doi: 10.3389/fmed.2021.631642. eCollection 2021.
6
Trauma-induced acquired reactive perforating collagenosis.创伤性获得性反应性穿通性胶原病
An Bras Dermatol. 2021 May-Jun;96(3):392-393. doi: 10.1016/j.abd.2020.06.022. Epub 2021 Mar 20.
7
Dermoscopic Patterns of Acquired Reactive Perforating Collagenosis.获得性反应性穿通性胶原病的皮肤镜表现
Dermatol Pract Concept. 2020 Dec 7;11(1):e2020085. doi: 10.5826/dpc.1101a85. eCollection 2021 Jan.
8
Case of acquired reactive perforating collagenosis induced by panitumumab for colon cancer.帕尼单抗诱发的结肠癌获得性反应性穿通性胶原病病例
J Dermatol. 2021 Feb;48(2):e114-e115. doi: 10.1111/1346-8138.15718. Epub 2020 Dec 2.
9
Evaluation of clinicopathological and treatment characteristics of 80 patients with acquired perforating dermatosis.评价 80 例获得性穿孔性皮肤病患者的临床病理及治疗特点。
Dermatol Ther. 2020 Nov;33(6):e14465. doi: 10.1111/dth.14465. Epub 2020 Nov 5.
10
Acquired reactive perforating collagenosis in association with prostate adenocarcinoma, chronic lymphocytic leukemia, and Graves' disease.获得性反应性穿通性胶原病伴前列腺腺癌、慢性淋巴细胞白血病及格雷夫斯病。
An Bras Dermatol. 2020 May-Jun;95(3):336-339. doi: 10.1016/j.abd.2019.09.029. Epub 2020 Apr 18.